# Effects of Hesperidin on Bone Mineral Density and Bone Metabolism of Postmenopausal Women

> **NCT00330096** · PHASE3 · COMPLETED · sponsor: **Société des Produits Nestlé (SPN)** · enrollment: 110 (estimated)

## Conditions studied

- Osteoporosis, Osteopenia

## Interventions

- **DRUG:** Hesperidin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00330096
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** 2009-04
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2015-10-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00330096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00330096, "Effects of Hesperidin on Bone Mineral Density and Bone Metabolism of Postmenopausal Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00330096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*